//
Popular
peptide
Tirzepatide 10mg
Dual GLP-1/GIP receptor agonist for metabolic research
Research areas:Metabolic
Other sizes:30mg
Sign in to view pricing
Dosage:10mg
Storage:Store lyophilized at -20°C, tightly sealed, away from heat, light and moisture. Once reconstituted, refrigerate at 2-8°C and use within 28 days.
Availability:In Stock
An account is required to view pricing and purchase research supplies. You will be asked to confirm research-use attestations when you register.
Sign in or create an accountFor Research Use Only
These products are intended for laboratory research use only and are not for human consumption. Not for use in food, drug, household, or cosmetic applications. All research should be conducted in accordance with applicable safety guidelines and regulations.
Description
Tirzepatide is a synthetic dual agonist that activates both GLP-1 and GIP receptors through a single peptide molecule. This dual-incretin mechanism has generated significant scientific interest for its multi-pathway approach to metabolic regulation research.
Research Summary
Phase 3 SURPASS trials demonstrated tirzepatide's differentiated receptor pharmacology, with researchers noting additive effects from combined GLP-1 and GIP pathway co-activation in metabolic studies.
Storage & Handling
Storage Temperature
Store lyophilized at -20°C, tightly sealed, away from heat, light and moisture. Once reconstituted, refrigerate at 2-8°C and use within 28 days.
Reconstitution
Reconstitute with bacteriostatic water for multi-dose use (supports the 28-day refrigerated window), or an appropriate sterile diluent per your research protocol. Allow the vial to reach room temperature before reconstitution.
Stability
Stable for 18-36 months when stored lyophilized at -20°C or below, sealed and protected from light and moisture. Once reconstituted, use within 28 days refrigerated at 2-8°C.
Dilution Calculator
For Research Use Only — Not for Human or Animal Consumption. This is a general laboratory dilution calculator (mass-to-volume concentration math) for in vitro research planning. It is not medical guidance, not a dosing tool, and not intended to support administration to humans or animals. All Nuvopeptide products are sold exclusively for in vitro laboratory research and have not been evaluated by the FDA.
Results
Concentration
10.00 mg/mL
Volume per Aliquot
0.050 mL
